Dr. Abhijit Moreshwar Godbole, MD

Dr. Godbole practices at Jefferson Regional in Pine Bluff, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Godbole's NPI, 1609135797, was assigned on May 9, 2012. Dr. Godbole holds Arkansas license E-11865.

Dr. Godbole's primary practice is Jefferson Regional, at 1600 West 40th Avenue, Pine Bluff, AR 71603 in Jefferson County. The practice phone is (870) 541-7100.

Dr. Godbole's primary practice is Jefferson Regional in Pine Bluff, Arkansas, part of University of Arkansas for Medical Sciences. Dr. Godbole is also affiliated with CHI St. Vincent Infirmary. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Godbole to 3 more hospitals, 7 medical groups, 1 group practice or clinic, 1 home health agency and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Godbole practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Godbole's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Godbole's licenses on file in 2 states: Arkansas and Pennsylvania.

CMS data shows 1,987 Medicare services from Dr. Godbole across 21 procedure codes in 2024, for 339 Medicare patients. Medicare paid $64,123 for them.

CMS counts 339 Medicare patients who saw Dr. Godbole in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Godbole's median patient age at 71, with 56% women.

In 2024, Dr. Godbole wrote 525 Medicare Part D claims for 123 patients. 82% of them were for generic drugs. CMS names the drug for 305 of them, across 13 drugs with 11 or more claims each, at $539,942 in total drug cost. In 2023, CMS named 556 claims across 21 drugs.

Dr. Godbole accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Godbole, published from 2011 to 2021. 2011 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, Cell Line, Tumor and Imidazoles. Dr. Godbole's most frequent co-author is Tyler Fugere, MD.

CMS Open Payments shows 579 general payments to Dr. Godbole from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $896.